Analgesic and Anti-Inflammatory Potential of Indole Derivatives

References

• D. Dou, W. Sha, Y. Diao, R. Su, Y. Qiao, Z. Yu, Z. Zhao, H. Li, Z. Chen, and Y. Xu, “Discovery of Pyrido [3, 4-b] Indol-1-One Derivatives as Novel Non-Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors,” Bioorganic Chemistry 119 (2022): 105541.
   PubMed Web of Science ®Google Scholar
• B. Zhang, Y. Duan, Y. Yang, Q. Mao, F. Lin, J. Gao, X. Dai, P. Zhang, Q. Li, J. Li, et al, “Design, Synthesis, and Biological Evaluation of N-(3-Cyano-1H-Indol-5/6-yl)-6-Oxo-1, 6-Dihydropyrimidine-4-Carboxamides and 5-(6-Oxo-1, 6-Dihydropyrimidin-2-yl)-1H-Indole-3-Carbonitriles as Novel Xanthine Oxidase Inhibitors,” European Journal of Medicinal Chemistry 227 (2022): 113928.
   PubMed Web of Science ®Google Scholar
• S. Razak, T. Afsar, N. Bibi, M. Abulmeaty, W. Qamar, A. Almajwal, A. Inam, A. D. Disi, M. Shabbir, and M. A. Bhat, “Molecular Docking, Pharmacokinetic Studies, and in Vivo Pharmacological Study of Indole Derivative 2-(5-Methoxy-2-Methyl-1H-Indole-3-yl)-N′-[(E)-(3-Nitrophenyl) Methylidene] Acetohydrazide as a Promising Chemoprotective Agent against Cisplatin Induced Organ Damage,” Scientific Reports 11, no. 1 (2021): 23.
   PubMed Web of Science ®Google Scholar
• M. F. Said, H. H. Georgey, and E. R. Mohammed, “Synthesis and Computational Studies of Novel Fused Pyrimidinones as a Promising Scaffold with Analgesic, Anti-Inflammatory and COX Inhibitory Potential,” European Journal of Medicinal Chemistry 224 (2021): 113682.
   PubMed Web of Science ®Google Scholar
• A. M. Ghanim, A. S. Girgis, B. M. Kariuki, N. Samir, M. F. Said, A. Abdelnaser, S. Nasr, M. S. Bekheit, M. F. Abdelhameed, A. J. Almalki, et al, “Design and Synthesis of Ibuprofen-Quinoline Conjugates as Potential Anti-Inflammatory and Analgesic Drug Candidates,” Bioorganic Chemistry 119 (2022): 105557.
   PubMed Web of Science ®Google Scholar
• E. M. Joshi, B. H. Heasley, M. D. Chordia, and T. L. Macdonald, “Chem. 2-ABT-S Oxide Detoxification by Glutathione S-Transferases A1-1, M1-1 and P1-1: Implications for Toxicity Associated with Zileuton,” Xenobiotica; the Fate of Foreign Compounds in Biological Systems 39, no. 3 (2009): 197–204.
   PubMed Web of Science ®Google Scholar
• S. Lakhdar, M. Westermaier, F. Terrier, R. Goumont, T. Boubaker, A. R. Ofial, and H. Mayr, “Nucleophilic Reactivities of Indoles,” The Journal of Organic Chemistry 71, no. 24 (2006): 9088–95.
   PubMed Web of Science ®Google Scholar
• M. A. Radwan, E. A. Ragab, N. M. Sabry, and S. M. El-Shenawy, “Synthesis and Biological Evaluation of New 3-Substituted Indole Derivatives as Potential Anti-Inflammatory and Analgesic Agents,” Bioorganic & Medicinal Chemistry 15, no. 11 (2007): 3832–41.
   PubMed Web of Science ®Google Scholar
• S. Simakov, V. Kartsev, A. Petrou, I. Nicolaou, A. Geronikaki, M. Ivanov, M. Kostic, J. Glamoclija, M. Sokovic, and D. Talea, “Vizirianakis, I. S. 4-(Indol-3-yl) Thiazole-2-Amines and 4-Ιndol-3-yl) Thiazole Acylamines as Νovel Antimicrobial Agents: Synthesis,” In Silico and in Vitro Evaluation Pharmaceuticals 14 (2021): 1096.
   Google Scholar
• R. Akunuri, V. Veerareddy, G. Kaul, A. Akhir, T. Unnissa, R. Parupalli, Y. V. Madhavi, S. Chopra, and S. Nanduri, “Synthesis and Antibacterial Evaluation of (E)-1-(1H-Indol-3-yl) Ethanone O-Benzyl Oxime Derivatives against MRSA and VRSA Strains,” Bioorganic Chemistry 116 (2021): 105288.
   PubMed Web of Science ®Google Scholar
• K. Rubab, M. A. Abbasi, S. Z. Siddiqui, S. A. A. Shah, M. Ashraf, M. A. Lodhi, F. A. Khan, M. Shahid, H. Fatima, I. Ahmad, et al, “Ahmad, I. Synthesis, Pharmacological Evaluation and Molecular Docking Studies of N-[2-(1H-Indol-3-yl) Acetyl] Arylsulfonohydrazides,” Pharmaceutical Chemistry Journal 55, no. 7 (2021): 665–78.
   Web of Science ®Google Scholar
• K. D. Tripathi, Essentials of Medical Pharmacology, 5th ed. (New Delhi, India: Jaypee Brothers Medical Publishers, 2004).
   Google Scholar
• S. M. Zahid Hosen, R. Das, Z. B. Rahim, N. Chowdhury, L. Paul, and D. Saha, “Study of Analgesic Activity of the Methanolic Extract of Acorus Calamus L. and Oroxylum Indicum Vent by Acetic Acid Induced Writhing Method,” Bulletin of Pharmaceutical Research 1 (2011): 63–7.
   Google Scholar
• S. Paul, and D. Saha, “Analgesic Activity of Methanol Extract of Plumbago Indica (L.) by Acetic Acid Induced Writhing Method,” Asian Journal of Pharmacy and Technology 2 (2012): 74–6.
   Google Scholar
• P. K. Patel, J. Sahu, and S. S. Chandel, “A Detailed Review on Nociceptive Models for the Screening of Analgesic Activity in Experimental Animals,” Journal of Neurologic Physical Therapy 2 (2016): 44–50.
   Google Scholar
• W. W. Wardakhan, O. M. Abdel-Salam, and G. A. Elmegeed, “Screening for Antidipressent, Sedative and Analgesic Activity of Novel Fused Thiophene Derivatives,” Acta Pharmaceutica (Zagreb, Croatia) 58, no. 1 (2008): 1–14.
   PubMed Web of Science ®Google Scholar
• Hossain, f, S. Saha, Md Mohinul Islam, Nasrin S., and Adhikari S. “Analgesic and anti-Inflammatory Activity of Commelinabenghalensis Linn,” Turkish Journal of Pharmaceutical Sciences 11 (2013): 25–32.
   Google Scholar
• T. Mohammad, Y. Mathur, and M. I. Hassan, “InstaDock: A Single-Click Graphical User Interface for Molecular Docking-Based Virtual High-Throughput Screening,” Brief Bioinformatics 24 (2021): bbaa279.
   Google Scholar
• N. M. Hassan, A. A. Alhossary, Y. Mu, and C. K. Kwoh, “Protein-Ligand Blind Docking Using QuickVina-W with Inter-Process Spatio-Temporal Integration,” Scientific Reports 7, no. 1 (2017): 13.
   PubMedGoogle Scholar
• O. Trott, and A. J. Olson, “AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading,” Journal of Computational Chemistry 31, no. 2 (2010): 455–61.
   PubMed Web of Science ®Google Scholar
• M. J. Abraham, T. Murtola, R. Schulz, S. Páll, J. C. Smith, B. Hess, and E. Lindahl, “GROMACS: High Performance Molecular Simulations through Multi-Level Parallelism from Laptops to Supercomputers,” SoftwareX 1–2 (2015): 19–25.
   Google Scholar
• M. Erol, I. Celik, U. Ince, H. Fatullayev, E. Uzunhisarcikli, and M. O. Puskullu, “Quantum Mechanical, Virtual Screening, Molecular Docking, Molecular Dynamics, ADME and Antimicrobial Activity Studies of Some New Indole-Hydrazone Derivatives as Potent Agents against E. faecalis,” Journal of Biomolecular Structure and Dynamics 40 (2021): 18112–81265.
   Web of Science ®Google Scholar
• S. Alqahtani, “In Silico ADME-Tox Modeling: Progress and Prospects,” Expert Opinion on Drug Metabolism & Toxicology 13, no. 11 (2017): 1147–58.
   PubMed Web of Science ®Google Scholar
• J. V. Turner, and S. Agatonovic-Kustrin, 5.29 - In Silico Prediction of Oral Bioavailability, In Comprehensive Medicinal Chemistry-II, edited by Taylor J. B. and Triggle. C. I. I. (USA: Elsevier Science, 2007), 699–724.
   Google Scholar
• C. A. S. Bergström, and P. Larsson, “Computational Prediction of Drug Solubility in Water-Based Systems: Qualitative and Quantitative Approaches Used in the Current Drug Discovery and Development Setting,” International Journal of Pharmaceutics 540, no. 1–2 (2018): 185–93.
   PubMed Web of Science ®Google Scholar
• U. A. Çevik, I. Celik, A. Işık, R. R. Pillai, T. E. Tallei, R. Yadav, Y. Ozkay, and Z. A. Kaplancıklı, “Synthesis, Molecular Modeling, Quantum Mechanical Calculations and ADME Estimation Studies of Benzimidazole-Oxadiazole Derivatives as Potent Antifungal Agents,” Journal of Molecular Structure 1252 (2022): 132095.
   Web of Science ®Google Scholar
• A. K. Umar, J. H. Zothantluanga, S. K. Aswin, S. Maulana, M. S. Zubair, H. Lalhlenmawia, M. Rudrapal, and D. Chetia, "Antiviral phytocompounds ‘ellagic acid’ and ‘(+)-sesamin’ of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular docking, molecular dynamics simulation studies, and bioactivity prediction," Structural Chemistry (2022). doi: 10.1007/s11224-022-01959-3.
   Google Scholar
• U. M. Zanger, and M. Schwab, “Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation,” Pharmacology & Therapeutics 138, no. 1 (2013): 103–41.
   PubMed Web of Science ®Google Scholar
• M. Rudrapal, N. Gogoi, D. Chetia, J. Khan, S. Banwas, B. Alshehri, M. A. Alaidarous, U. D. Laddha, & S. J. Khairnar, and S. G. Walode, “Repurposing of Phytomedicine- Derived Bioactive Compounds with Promising anti-SARS-CoV-2 Potential: Molecular Docking, MD Simulation and Drug-Likeness/ADMET Studies,” Saudi Journal of Biological Sciences 29, no. 4 (2022a): 2432–46.
   PubMed Web of Science ®Google Scholar
• M. Rudrapal, I. Celik, J. Khan, M. A. Ansari, M. N. Alomary, F. A. Alatawi, R. Yadav, T. Sharma, T. E. Tallei, P. K. Pasala, et al, “Identification of Bioactive Molecules from Triphala (Ayurvedic Herbal Formulation) as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) through Computational Investigations,” Journal of King Saud University Science 34, no. 3 (2022b): 101826.
   PubMed Web of Science ®Google Scholar
• M. Rudrapal, I. Celik, S. Chinnam, M. A. Ansari, J. Khan, S. Alghamdi, M. Almehmadi, J. H. Zothantluanga, and S. J. Khairnar, “Phytocompounds of Indian Spices as Inhibitors of SARS-CoV-2 Mpro and PLpro: Molecular Docking, Molecular Dynamics, and ADMET Studies,” Saudi Journal of Biological Sciences 29 (2022c): 3456–3465.
   PubMed Web of Science ®Google Scholar
• P. K. Pasala, R. Abbas Shaik, M. Rudrapal, J. Khan, M. A. Alaidarous, S. Jagdish Khairnar, A. R. Bendale, V. D. Naphade, R. Kumar Sahoo, J. H. Zothantluanga, et al, “Cerebroprotective Effect of Aloe Emodin: In Silico and in Vivo Studies,” Saudi Journal of Biological Sciences 29, no. 2 (2022a): 998–1005.
   PubMed Web of Science ®Google Scholar
• P. K. Pasala, S. S. L. Siva Reddy, N. Silvia, D. Y. Reddy, A. Sampath, N. Dorababu, N. V. L. Sirisha Mulukuri, K. T. Sunil Kumar, S. M. Chandana, M. C. Chetty, et al, “In Vivo Immunomodulatory Activity and in Silico Study of Albizia Procera Bark Extract on Doxorubicin Induced Immunosuppressive Rats,” Journal of King Saud University, Science 34, no. 3 (2022b): 101828.
   Web of Science ®Google Scholar
• P. K. Pasala, R. K. Uppara, M. Rudrapal, J. H. Zothantluanga, and A. K. Umar, “Silybin Phytosomes Attenuates Cerebral Ischemia-Reperfusion Injury in Rats by Suppressing Oxidative Stress and Reducing Inflammatory Response: In-Vivo and in-Silico Approaches,” Journal of Biochemical and Molecular Toxicology 36 (2022c): e23072.
   PubMed Web of Science ®Google Scholar
• I. M. Othman, M. H. Mahross, M. A. Gad-Elkareem, M. Rudrapal, N. Gogoi, D. Chetia, K. Aouadi, M. Snoussi, and A. Kadri, “Toward a Treatment of Antibacterial and Antifungal Infections: Design, Synthesis and in Vitro Activity of Novel Arylhydrazothiazolylsulfonamides Analogues and Their Insight of DFT, Docking and Molecular Dynamic Simulation,” Journal of Molecular Structure 1243 (2021): 130862.
   Web of Science ®Google Scholar
• J. A. Junejo, K. Zaman, M. Rudrapal, I. Celik, and E. I. Attah, “Antidiabetic Bioactive Compounds from Tetrastigma Angustifolia (Roxb.) Deb and Oxalis Debilis Kunth.: Validation of Ethnomedicinal Claim by in Vitro and in Silico Studies,” South African Journal of Botany 143 (2021): 164–75.
   Web of Science ®Google Scholar
• N. Hussain, B. B. Kakoti, M. Rudrapal, K. K. Sarwa, I. Celik, E. I. Attah, S. J. Khairnar, S. Bhattacharya, R. K. Sahoo, and S. G. Walode, “Bioactive Antidiabetic Flavonoids from the Stem Bark of Cordia Dichotoma Forst.: Identification, Docking and ADMET Studies,” Molbank 2021, no. 2 (2021): M1234.
   Web of Science ®Google Scholar
• A. E. James, U. C. Okoro, M. A. Ezeokonkwo, C. R. Bhimapaka, M. Rudrapal, D. I. Ugwu, N. Gogoi, D. Chetia, and I. Celik, “Design, Synthesis, Molecular Docking, Molecular Dynamics and in Vivo Antimalarial Activity of New Dipeptidesulfonamides,” ChemSelect 7, no. 5 (2022): e202103908.
   Google Scholar
• J. H. Zothantluanga, M. Abdalla, M. Rudrapal, Q. Tian, D. Chetia, and J. Li, “Computational Investigations for Identification of Bioactive Molecules from Baccaurea Ramiflora and Bergenia Ciliate as Inhibitors of SARS-CoV-2 Mpro,” Polycyclic Aromatic Compounds (2022): 1–29.
   Web of Science ®Google Scholar
• M. Rudrapal, A. R. Issahaku, C. Agoni, A. R. Bendale, A. Nagar, M. E. Soliman, and D. Lokwani, “In Silico Screening of Phytopolyphenolics for the Identification of Bioactive Compounds as Novel Protease Inhibitors Effective against SARS-CoV-2,” Journal of Biomolecular Structure and Dynamics 2021 (2021): 1–17.
   Google Scholar
• S. Ghosh, D. Chetia, N. Gogoi, and M. Rudrapal, “Design, Molecular Docking, Drug-Likeness and Molecular Dynamics Studies of 1,2,4-Trioxane Derivatives as Novel P. falciparum Falcipain-2 (FP-2) Inhibitors,” BioTechnologia 102, no. 3 (2021): 257–75.
   Google Scholar
• U. Ayhan, and T. Nurten, “Effect of Frontier Molecular Orbitals of Substituents in 5-Position of Uracil Base Pairs in Vacuum and Water,” Journal of Theoretical & Computational Chemistry 16, no. 7 (2017): 1750066.
   Web of Science ®Google Scholar
• M. M. El-Nahass, M. A. Kamel, A. F. El-Deeb, A. A. Atta, and S. Y. Huthaily, “Density Functional Theory (DFT) Investigation of Molecular Structure and Frontier Molecular Orbitals (FMOs) of P-N,N-Dimethylaminobenzylidenemalononitrile (DBM),” Spectrochimica Acta Part A, Molecular and Biomolecular Spectroscopy 79, no. 5 (2011): 1499–504.
   PubMed Web of Science ®Google Scholar
• C. Oostenbrink, A. Villa, A. E. Mark, and W. F. Van Gunsteren, “A Biomolecular Force Field Based on the Free Enthalpy of Hydration and Solvation: The GROMOS Force‐Field Parameter Sets 53A5 and 53A6,” Journal of Computational Chemistry 25, no. 13 (2004): 1656–76.
   PubMed Web of Science ®Google Scholar
• A. W. Schüttelkopf, and D. M. Van Aalten, “PRODRG: A Tool for High-Throughput Crystallography of Protein–Ligand Complexes,” Acta Crystallographica Section D, Biological Crystallography 60, no. Pt 8 (2004): 1355–63.
   PubMedGoogle Scholar
• R. Kumari, R. Kumar, and A. Lynn, Open Source Drug Discovery Consortium. “Lynn, A. g_Mmpbsa- a GROMACS Tool for High-Throughput MM-PBSA Calculations,” Journal of Chemical Information and Modeling 54, no. 7 (2014): 1951–62.
   PubMed Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7, no. 1 (2017): 13.
   PubMedGoogle Scholar
• M. A. Bhat, M. A. Al-Omar, M. Raish, M. A. Ansari, H. A. Abuelizz, A. H. Bakheit, and A. M. Naglah, “Indole Derivatives as Cyclooxygenase Inhibitors: Synthesis, Biological Evaluation and Docking Studies,” Molecules 23, no. 6 (2018): 1250.
   PubMed Web of Science ®Google Scholar
• A. Abelian, M. Dybek, J. Wallach, B. Gaye, and A. Adejare, Chapter 6 - Pharmaceutical Chemistry, In Remington (Twenttythree Edition), edited by E. Adejare (USA: Elsevier, 2021), 105–28.
   Google Scholar
• M. J. R. Yunta, “It is Important to Compute Intramolecular Hydrogen Bonding in Drug Design?” American Journal of Modeling and Optimization 5 (2017): 24–57.
   Google Scholar
• S. J. Park, and M. K. Seo, “Chapter 4 - Solid-Solid Interfaces,” In Interface Science and Composites, edited by S.-J. Park and T. Seo, Vol. 18. (Amsterdam, Netherlands: Elsevier, 2011), 253–331.
   Google Scholar
• K. Roy, S. Kar, and R. N. Das, “Chapter 1 - Background of QSAR and Historical Developments,” In Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment, edited by K. Roy, S. Kar, and R. A. Das. (USA: Elsevier, 2015), 1–46.
   Google Scholar
• D. E. Arthur, and A. Uzairu, “Molecular Docking Studies on the Interaction of NCI Anticancer Analogues with Human Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit,” Journal of King Saud University, Science 31, no. 4 (2019): 1151–66.
   Web of Science ®Google Scholar
• I. Celik, M. Erol, and Z. Duzgun, “In Silico Evaluation of Potential Inhibitory Activity of Remdesivir, Favipiravir, Ribavirin and Galidesivir Active Forms on SARS-CoV-2 RNA Polymerase,” Molecular Diversity 2021 (2021): 1–14.
   Google Scholar
• Y. Huang, B. Zhang, J. Li, H. Liu, Y. Zhang, Z. Yang, and W. Liu, “Design, Synthesis, Biological Evaluation and Docking Study of Novel Indole-2-Amide as anti-Inflammatory Agents with Dual Inhibition of COX and 5-LOX,” European Journal of Medicinal Chemistry 180 (2019): 41–50.
   PubMed Web of Science ®Google Scholar
• K. Sargsyan, C. Grauffel, and C. Lim, “How Molecular Size Impacts RMSD Applications in Molecular Dynamics Simulations,” Journal of Chemical Theory and Computation 13, no. 4 (2017): 1518–24.
   PubMed Web of Science ®Google Scholar
• M. Rahman, M. Junaid, S. M. Hosen, M. Mostafa, L. Liu, and K. Benkendorff, “Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition,” Molecules 26, no. 21 (2021): 6538.
   PubMed Web of Science ®Google Scholar
• S. Genheden, and U. Ryde, “The MM/PBSA and MM/GBSA Methods to Estimate Ligand-Binding Affinities,” Expert Opinion on Drug Discovery 10, no. 5 (2015): 449–61.
   PubMed Web of Science ®Google Scholar